Liu Gu, Li Chang-Min, Xie Fei, Li Qi-Lai, Liao Liang-Yan, Jiang Wen-Jun, Li Xiao-Pan, Lu Guan-Ming
Department of Gastrointestinal Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510630, Guangdong Province, China.
Department of Gastrointestinal Surgery, Chenzhou Third People's Hospital, Chenzhou 423000, Hunan Province, China.
World J Gastrointest Oncol. 2024 Jan 15;16(1):182-196. doi: 10.4251/wjgo.v16.i1.182.
Colorectal cancer (CRC) plays a significant role in morbidity, mortality, and economic cost in the Belt and Road Initiative ("B and R") countries. In addition, these countries have a substantial consumption of processed meat. However, the burden and trend of CRC in relation to the consumption of a diet high in processed meat (DHPM-CRC) in these "B and R" countries remain unknown.
To analyze the burden and trend of DHPM-CRC in the "B and R" countries from 1990 to 2019.
We used the 2019 Global Burden of Disease Study to collate information regarding the burden of DHPM-CRC. Numbers and age-standardized rates (ASRs) of deaths along with the disability-adjusted life years (DALYs) were determined among the "B and R" countries in 1990 and 2019. Using joinpoint regression analysis, the average annual percent change (AAPC) was used to analyze the temporal trends of age-standardized DALYs rate (ASDALR) from 1990 to 2019 and in the final decade (2010-2019).
We found geographical differences in the burden of DHPM-CRC among "B and R" countries, with the three highest-ranking countries being the Russian Federation, China, and Ukraine in 1990, and China, the Russian Federation, and Poland in 2019. The burden of DHPM-CRC generally increased in most member countries from 1990 to 2019 (all < 0.05). The absolute number of deaths and DALYs in DHPM-CRC were 3151.15 [95% uncertainty interval (UI) 665.74-5696.64] and 83249.31 (95%UI 15628.64-151956.31) in China in 2019. However, the number of deaths (2627.57-2528.51) and DALYs (65867.39-55378.65) for DHPM-CRC in the Russian Federation has declined. The fastest increase in ASDALR for DHPM-CRC was observed in Vietnam, Southeast Asia, with an AAPC value of 3.90% [95% confidence interval (CI): 3.63%-4.16%], whereas the fastest decline was observed in Kyrgyzstan, Central Asia, with an AAPC value of -2.05% (95% CI: -2.37% to -1.73%). A substantial upward trend in ASR of mortality, years lived with disability, years of life lost, and DALYs from DHPM-CRC changes in 1990-2019 and the final decade (2010-2019) for most Maritime Silk Route members in East Asia, South Asia, Southeast Asia, North Africa, and the Middle East, as well as Central Europe, while those of the most Land Silk Route members in Central Asia and Eastern Europe have decreased markedly (all < 0.05). The ASDALR for DHPM-CRC increased more in males than in females (all < 0.05). For those aged 50-74 years, the ASDALR for DHPM-CRC in 40 members exhibited an increasing trend, except for 20 members, including 7 members in Central Asia, Maldives, and 12 high or high-middle social development index (SDI) members in other regions (all < 0.05).
The burden of DHPM-CRC varies substantially across "B and R" countries and threatens public health. Relevant evidence-based policies and interventions tailored to the different trends of countries in SDIs or Silk Routes should be adopted to reduce the future burden of CRC in "B and R" countries via extensive collaboration.
在“一带一路”国家中,结直肠癌(CRC)在发病率、死亡率和经济成本方面都扮演着重要角色。此外,这些国家的加工肉类消费量很大。然而,在这些“一带一路”国家中,与高加工肉类饮食相关的结直肠癌(DHPM-CRC)负担和趋势仍不明确。
分析1990年至2019年“一带一路”国家中DHPM-CRC的负担和趋势。
我们利用2019年全球疾病负担研究来整理关于DHPM-CRC负担的信息。确定了1990年和2019年“一带一路”国家中死亡人数、年龄标准化率(ASRs)以及伤残调整生命年(DALYs)。使用Joinpoint回归分析,平均年度百分比变化(AAPC)用于分析1990年至2019年以及最后十年(2)的年龄标准化DALYs率(ASDALR)的时间趋势。
我们发现“一带一路”国家中DHPM-CRC负担存在地理差异,1990年排名前三的国家是俄罗斯联邦、中国和乌克兰,2019年是中国、俄罗斯联邦和波兰。从1990年到2019年,大多数成员国中DHPM-CRC的负担普遍增加(所有P<0.05)。2019年中国DHPM-CRC的死亡绝对数和DALYs分别为3151.15[95%不确定区间(UI)665.74-5696.64]和83249.31(95%UI 15628.64-151956.31)。然而,俄罗斯联邦DHPM-CRC的死亡人数(2627.57-2528.51)和DALYs(65867.39-55378.65)有所下降。在东南亚的越南,观察到DHPM-CRC的ASDALR增长最快,AAPC值为3.90%[95%置信区间(CI):3.63%-4.16%],而在中亚的吉尔吉斯斯坦观察到下降最快,AAPC值为-2.05%(95%CI:-2.37%至-1.73%)。1990-2019年以及最后十年(2010-2019),东亚、南亚、东南亚、北非和中东以及中欧的大多数海上丝绸之路成员国中,DHPM-CRC导致的死亡率、伤残生存年数、生命损失年数和DALYs的ASR呈大幅上升趋势,而中亚和东欧的大多数陆上丝绸之路成员国则明显下降(所有P<0.05)。DHPM-CRC导致的ASDALR在男性中比女性增加更多(所有P<0.05)。对于50-74岁的人群,40个成员国中DHPM-CRC的ASDALR呈上升趋势,只有20个成员国除外,包括中亚的7个成员国、马尔代夫以及其他地区的12个高或高中社会发展指数(SDI)成员国(所有P<0.05)。
“一带一路”国家中DHPM-CRC的负担差异很大,对公众健康构成威胁。应通过广泛合作,针对不同国家在SDI或丝绸之路方面的不同趋势,采取相关基于证据的政策和干预措施,以减轻“一带一路”国家未来结直肠癌的负担。